TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36088628

Group type: EXPERIMENTAL
Intervention: Denosumab (DMAb) short-term (≤3 years; n=262)
Number of subjects: 752

Group type: EXPERIMENTAL
Intervention: Denosumab (DMAb) long-term (>3 years; n=213)
Number of subjects: 752

Group type: COMPARATOR
Intervention: Placebo (n=327)
Number of subjects: 752

Group type: EXPERIMENTAL
Intervention: Denosumab (DMAb) duration
Number of subjects: 752
Study: 34694155

Group type: EXPERIMENTAL
Intervention: Full implementation support from a knowledge broker
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Partial implementation support from a knowledge broker
Number of subjects: 18
Study: 35681097

Group type: EXPERIMENTAL
Intervention: Lactoferrin 100 mg/day for 3 months
Number of subjects: 80

Group type: COMPARATOR
Intervention: Ferrous sulfate 6 mg/kg/day for 3 months
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Comparison of Lactoferrin vs Ferrous sulfate
Number of subjects: 80
Study: 34117829

Group type: EXPERIMENTAL
Intervention: QLB‐III
Number of subjects: 80

Group type: COMPARATOR
Intervention: QLB‐II
Number of subjects: 80
Study: 34397455

Group type: EXPERIMENTAL
Intervention: High tie surgery
Number of subjects: 8287
Study: 33736484

Group type: EXPERIMENTAL
Intervention: Digital therapeutic mobile application
Number of subjects: 146

Group type: COMPARATOR
Intervention: Standard weekly coaching sessions (Control)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Digital therapeutic mobile application (per-protocol)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Standard treatment (Control)
Number of subjects: 146
Study: 34196973

Group type: EXPERIMENTAL
Intervention: Robenacoxib (n=222)
Number of subjects: 449

Group type: COMPARATOR
Intervention: Placebo (n=227)
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Robenacoxib
Number of subjects: 449
Study: 32434498

Group type: EXPERIMENTAL
Intervention: Intra-articular injection of autologous adipose tissue
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intra-articular injection of platelet-rich plasma (PRP)
Number of subjects: 0
Study: 35025164

Group type: EXPERIMENTAL
Intervention: Acupuncture and moxibustion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 33880752

Group type: EXPERIMENTAL
Intervention: Lactiplantibacillus plantarum 299v (Lp299v, 1010 colony forming units), 4.2 mg iron, 12 mg ascorbic acid and 30 µg folic acid (Lp)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326
Study: 32836103

Group type: EXPERIMENTAL
Intervention: Excellent/very good health status
Number of subjects: 1116

Group type: EXPERIMENTAL
Intervention: Good health status
Number of subjects: 1116

Group type: EXPERIMENTAL
Intervention: Fair health status
Number of subjects: 1116

Group type: EXPERIMENTAL
Intervention: Poor health status
Number of subjects: 1116
Study: 36104105

Group type: EXPERIMENTAL
Intervention: Physiotherapy-led breathing exercises for 6 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Music therapy-led breathing exercises for 6 weeks
Number of subjects: 40
Study: 34173669

Group type: EXPERIMENTAL
Intervention: General payments (GPs)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Research funding (RF)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: RCTs involving any type of systemic therapy
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Medical oncologist PIs
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Trials with phase III components
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: RCTs involving radiotherapy
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: PIs having accepted payment(s) from the manufacturer of the drug utilized in their RCT
Number of subjects: 91
Study: 33363073

Group type: EXPERIMENTAL
Intervention: Community-based family workshop intervention for 6 months
Number of subjects: 104

Group type: COMPARATOR
Intervention: Routine parenting guidance
Number of subjects: 104
Study: 32101663

Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus neoadjuvant chemotherapy (200 mg every 3 weeks)
Number of subjects: 1174

Group type: COMPARATOR
Intervention: Placebo plus neoadjuvant chemotherapy
Number of subjects: 1174

Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus neoadjuvant chemotherapy
Number of subjects: 1174
Study: 34470186

Group type: EXPERIMENTAL
Intervention: MNT administered monthly (Group A)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: MNT administered every 3 months (Group B)
Number of subjects: 98

Group type: COMPARATOR
Intervention: No access to nutritional therapy (Group C)
Number of subjects: 98
Study: 32315396

Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric assessment (CGA) conducted in the emergency department (ED)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comprehensive geriatric assessment (CGA)
Number of subjects: 0
Study: 36237734

Group type: EXPERIMENTAL
Intervention: Multi-Component Psychological Intervention
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 24
Study: 32816842

Group type: EXPERIMENTAL
Intervention: TARGIT‐IORT
Number of subjects: 2298

Group type: COMPARATOR
Intervention: EBRT
Number of subjects: 2298
Study: 36282220

Group type: COMPARATOR
Intervention: Erector spinae plane block (ESPB) with 20 mL 0.375% bupivacaine
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Thoracal paravertebral block (TPVB) with 20 mL 0.375% bupivacaine
Number of subjects: 83
Study: 35528962

Group type: EXPERIMENTAL
Intervention: Tailored intervention package including in-person education about TB management, bimonthly electronic refreshers, context-specific selection of referral pathways, and access to a TB-reporting app.
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group receiving standard care without the tailored intervention package.
Number of subjects: 36
Study: 32063222

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral stress management
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine prenatal examination and health education
Number of subjects: 100
Study: 35304614

Group type: EXPERIMENTAL
Intervention: Genicular artery embolization using imipenem/cilastatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Genicular artery embolization using microspheres
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genicular artery embolization (both interventions)
Number of subjects: 0
Study: 36166781

Group type: EXPERIMENTAL
Intervention: Video visits
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Remote testing
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Virtual second opinions
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: eConsults
Number of subjects: 135
Study: 34365952

Group type: EXPERIMENTAL
Intervention: Proximal tibial anatomical axis measurement
Number of subjects: 200

Group type: COMPARATOR
Intervention: Whole tibial anatomical axis measurement
Number of subjects: 200
Study: 34173298

Group type: EXPERIMENTAL
Intervention: Alpelisib plus fulvestrant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control not specified
Number of subjects: 0
Study: 33066603

Group type: EXPERIMENTAL
Intervention: Nutrition literacy
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Dietary adherence rate
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Limited nutrition literacy
Number of subjects: 218
Study: 32127868

Group type: EXPERIMENTAL
Intervention: Insomnia
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Change in sleep habits
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Not waking up feeling rested
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Decrease in sleep
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Increase in sleep
Number of subjects: 436
Study: 35957925

Group type: EXPERIMENTAL
Intervention: Coronary artery disease (CAD)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Lower educational status
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Higher P-selectin levels
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Age > 65 years
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: 6-Minute Walk Test < 432 m
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Serum glucose > 120 mg/dL
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Serum cortisol > 10 μg/dL
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Leptin ≥ 15 ng/mL
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: GDNF ≥ 20 pg/mL
Number of subjects: 145
Study: 33632160

Group type: EXPERIMENTAL
Intervention: Online haemodiafiltration (HDF)
Number of subjects: 1620

Group type: COMPARATOR
Intervention: Haemodialysis (HD)
Number of subjects: 1620
Study: 33203365

Group type: EXPERIMENTAL
Intervention: Collaborative care (CC) for depression
Number of subjects: 731

Group type: EXPERIMENTAL
Intervention: Collaborative care (CC) for anxiety
Number of subjects: 731

Group type: COMPARATOR
Intervention: Treatment-as-usual (control group)
Number of subjects: 731
Study: 33840474

Group type: EXPERIMENTAL
Intervention: Oxygen delivery strategy (maintaining an oxygen delivery index value >300 mL/min/m2 through pump flow adjustments)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Conventional strategy (target pump flow based on body surface area)
Number of subjects: 300
Study: 32861603

Group type: EXPERIMENTAL
Intervention: Taurine 3,000 mg/day for 8 weeks
Number of subjects: 46
Study: 32273749

Group type: EXPERIMENTAL
Intervention: Educational intervention in pain management for nursing staff, including classroom (quality circles) and web-based training.
Number of subjects: 569

Group type: COMPARATOR
Intervention: Control group (no educational intervention).
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: Educational intervention in pain management for nursing staff.
Number of subjects: 569
Study: 33161276

Group type: EXPERIMENTAL
Intervention: Generation 2 posture bra
Number of subjects: 24

Group type: COMPARATOR
Intervention: Everyday bra
Number of subjects: 24

Group type: COMPARATOR
Intervention: No bra
Number of subjects: 24
Study: 32736338

Group type: EXPERIMENTAL
Intervention: NMES 80% BFR
Number of subjects: 20

Group type: COMPARATOR
Intervention: NMES 40% BFR
Number of subjects: 20

Group type: COMPARATOR
Intervention: NMES 60% BFR
Number of subjects: 20

Group type: COMPARATOR
Intervention: NMES alone
Number of subjects: 20
Study: 34748214

Group type: EXPERIMENTAL
Intervention: Conversational agent (dialogic reading)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Adult reading partner (non-dialogic reading)
Number of subjects: 117
Study: 34563585

Group type: EXPERIMENTAL
Intervention: Luseogliflozin 2.5 mg/day
Number of subjects: 56

Group type: COMPARATOR
Intervention: DPP-4 inhibitor
Number of subjects: 56
Study: 33141657

Group type: EXPERIMENTAL
Intervention: Annual mammography screening (film mammography, two views at first screen and single view thereafter)
Number of subjects: 160836

Group type: EXPERIMENTAL
Intervention: Annual mammography screening
Number of subjects: 160836

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 160836
Study: 35102226

Group type: EXPERIMENTAL
Intervention: Desogestrel (DSG 150 µg/d, n=50)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Medroxyprogesterone acetate (MPA 10 mg/d, n=54)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Desogestrel (DSG)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Medroxyprogesterone acetate (MPA)
Number of subjects: 104
Study: 33246344

Group type: EXPERIMENTAL
Intervention: Logistic regression model using 949 variates
Number of subjects: 261758

Group type: EXPERIMENTAL
Intervention: Logistic regression model using 72 variates
Number of subjects: 261758

Group type: EXPERIMENTAL
Intervention: Logistic regression model
Number of subjects: 261758
Study: 32346706

Group type: EXPERIMENTAL
Intervention: Continuous curvilinear buccal‐cervical incision
Number of subjects: 87

Group type: COMPARATOR
Intervention: Conventional cervical T shaped incision combined with a buccal incision
Number of subjects: 87
Study: 36293928

Group type: EXPERIMENTAL
Intervention: Electrotherapy group (46 subjects)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sham electrotherapy group (44 subjects)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Comparison between groups
Number of subjects: 90
Study: 34528981

Group type: EXPERIMENTAL
Intervention: LGG fermented milk (150 mL containing 108 CFU mL‐1 LGG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lactic-acidified milk (placebo)
Number of subjects: 20
Study: 33992259

Group type: EXPERIMENTAL
Intervention: CT + NM
Number of subjects: 66

Group type: COMPARATOR
Intervention: CT + sham NM
Number of subjects: 66

Group type: COMPARATOR
Intervention: WLC
Number of subjects: 66
Study: 35988204

Group type: EXPERIMENTAL
Intervention: BC‐He novel nano bio‐vascular stent
Number of subjects: 98

Group type: COMPARATOR
Intervention: Conventional nursing (group A)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Perioperative nursing (group B)
Number of subjects: 98
Study: 33978711

Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Baricitinib 2 mg
Number of subjects: 124
Study: 33034565

Group type: EXPERIMENTAL
Intervention: Technology-enabled self-monitoring program
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Technology-enabled self- and remote-monitoring program
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 18
Study: 35822565

Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 371

Group type: COMPARATOR
Intervention: valsartan
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: medication withdrawal
Number of subjects: 371

Group type: COMPARATOR
Intervention: maintenance group
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: not specified
Number of subjects: 371
Study: 34234539

Group type: EXPERIMENTAL
Intervention: active cTBS
Number of subjects: 28

Group type: COMPARATOR
Intervention: sham cTBS
Number of subjects: 28
Study: 35881121

Group type: EXPERIMENTAL
Intervention: High-dose tranexamic acid (30 mg/kg bolus, 16 mg/kg/h maintenance, 2 mg/kg prime)
Number of subjects: 3079

Group type: COMPARATOR
Intervention: Low-dose tranexamic acid (10 mg/kg bolus, 2 mg/kg/h maintenance, 1 mg/kg prime)
Number of subjects: 3079

Group type: EXPERIMENTAL
Intervention: High-dose tranexamic acid
Number of subjects: 3079

Group type: COMPARATOR
Intervention: Low-dose tranexamic acid
Number of subjects: 3079
Study: 32279172

Group type: EXPERIMENTAL
Intervention: Fecal Microbiota Transplantation (FMT)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Antiviral therapy (AVT)
Number of subjects: 29
Study: 36183506

Group type: EXPERIMENTAL
Intervention: Fractional Radiofrequency (FRF)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Microneedling
Number of subjects: 30
Study: 33748833

Group type: EXPERIMENTAL
Intervention: High-dose influenza vaccine
Number of subjects: 5200

Group type: COMPARATOR
Intervention: Standard-dose influenza vaccine
Number of subjects: 5200
Study: 35324989

Group type: EXPERIMENTAL
Intervention: 140 Hz transcranial alternating current stimulation (tACS) at 1.0 mA
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 140 Hz transcranial alternating current stimulation (tACS)
Number of subjects: 17
Study: 33717093

Group type: EXPERIMENTAL
Intervention: Icaritin
Number of subjects: 0
Study: 32589056

Group type: EXPERIMENTAL
Intervention: Early intervention arm (educational information mailed to patients and their providers)
Number of subjects: 80000

Group type: COMPARATOR
Intervention: Delayed intervention arm (educational information mailed to providers of patients approximately 12 months later)
Number of subjects: 80000
Study: 35610712

Group type: EXPERIMENTAL
Intervention: CHW-led intervention (monthly household visits for 1 year)
Number of subjects: 869
Study: 34051389

Group type: EXPERIMENTAL
Intervention: One dose of HPV vaccine
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Two doses of HPV vaccine
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Three doses of HPV vaccine
Number of subjects: 37
Study: 34159751

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of amlodipine 5 mg, losartan 100 mg, and chlorthalidone 25 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Separate components (loose combination) of amlodipine/losartan 5/100 mg and chlorthalidone 25 mg
Number of subjects: 60
Study: 33910578

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy
Number of subjects: 8094

Group type: EXPERIMENTAL
Intervention: Fibrinogen levels ≥ 3.5 g/L
Number of subjects: 8094

Group type: EXPERIMENTAL
Intervention: Fibrinogen quartiles
Number of subjects: 8094

Group type: EXPERIMENTAL
Intervention: Cardiovascular adverse events of special interest (AESIs)
Number of subjects: 8094
Study: 33369660

Group type: EXPERIMENTAL
Intervention: IVR training platform for reverse shoulder arthroplasty; participants could repeat the module indefinitely.
Number of subjects: 18
Study: 35296402

Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 18262

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18262

Group type: EXPERIMENTAL
Intervention: History of atrial fibrillation
Number of subjects: 18262

Group type: COMPARATOR
Intervention: Randomized treatment (Alirocumab vs Placebo)
Number of subjects: 18262
Study: 32970367

Group type: EXPERIMENTAL
Intervention: Basic psychological need-satisfying activities intervention (n = 98)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control (neutral comparison group, n = 110)
Number of subjects: 208
Study: 35468864

Group type: EXPERIMENTAL
Intervention: Tai Chi combined with Kinesio taping
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 32139381

Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg
Number of subjects: 396

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 396
Study: 36480510

Group type: EXPERIMENTAL
Intervention: Active tDCS (20 minutes at 2 mA) for 10 daily sessions plus 5 follow up sessions
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham tDCS (30 seconds at 2 mA, 19 minutes at 0 mA) for 10 daily sessions plus 5 follow up sessions
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 50
Study: 33221862

Group type: EXPERIMENTAL
Intervention: Healthy Schools, Healthy Students (HSHS) intervention including education sessions, cafeteria coaching, and taste testing
Number of subjects: 1057

Group type: EXPERIMENTAL
Intervention: Healthy Schools, Healthy Students (HSHS)
Number of subjects: 1057
Study: 33121256

Group type: EXPERIMENTAL
Intervention: Breast milk odor
Number of subjects: 84

Group type: COMPARATOR
Intervention: Formula milk odor
Number of subjects: 84
Study: 35149568

Group type: EXPERIMENTAL
Intervention: Intervention group receiving three individual counselling sessions on CIH within 3 months
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Control group receiving treatment as usual, no CIH counselling
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1500
Study: 34296283

Group type: EXPERIMENTAL
Intervention: Trastuzumab emtansine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trastuzumab, pertuzumab and docetaxel
Number of subjects: 0
Study: 35488270

Group type: EXPERIMENTAL
Intervention: Narrative e-Writing Intervention (NeW-I)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: NeW-I
Number of subjects: 26
Study: 34459842

Group type: EXPERIMENTAL
Intervention: Blended collaborative care for HF and depression (12 months)
Number of subjects: 756

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 756

Group type: COMPARATOR
Intervention: Enhanced usual care (eUC)
Number of subjects: 756
Study: 34034627

Group type: EXPERIMENTAL
Intervention: Random forest algorithm for predicting problem coping experiences (PCE) effects in cognitive-behavioral therapy
Number of subjects: 1010
Study: 32564661

Group type: EXPERIMENTAL
Intervention: Active TENS
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control
Number of subjects: 78
Study: 34321058

Group type: EXPERIMENTAL
Intervention: Immediate tapering of opioids
Number of subjects: 140

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 140
Study: 32440730

Group type: EXPERIMENTAL
Intervention: Inulin-type fructans (16 g)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (maltodextrin, 16 g)
Number of subjects: 25
Study: 35658725

Group type: EXPERIMENTAL
Intervention: Local Anesthesia (LA)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Brachial Plexus Block (BP)
Number of subjects: 70
Study: 34344029

Group type: EXPERIMENTAL
Intervention: Givosiran (monthly subcutaneous injection)
Number of subjects: 0
Study: 32711554

Group type: EXPERIMENTAL
Intervention: High-dose platinum-based chemotherapy
Number of subjects: 114

Group type: COMPARATOR
Intervention: Non-BRCA-like patients
Number of subjects: 114
Study: 35089960

Group type: EXPERIMENTAL
Intervention: Metformin (2g/day)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Metformin and Placebo (PCOS mothers)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Low-risk reference population
Number of subjects: 58
Study: 33650197

Group type: EXPERIMENTAL
Intervention: Losartan, 25 mg, twice a day
Number of subjects: 80

Group type: COMPARATOR
Intervention: Amlodipine, 5 mg per day
Number of subjects: 80
Study: 32221052

Group type: EXPERIMENTAL
Intervention: Metronomic chemotherapy
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 36199257

Group type: EXPERIMENTAL
Intervention: High-intensity interval training bout
Number of subjects: 30

Group type: COMPARATOR
Intervention: No exercise
Number of subjects: 30
Study: 33096006

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (interval, continuous, combination) for 3 months
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 83
Study: 32229466

Group type: EXPERIMENTAL
Intervention: Narrative Video (NV)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Non-Narrative Video (NNV)
Number of subjects: 22
Study: 36415996

Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA, 20 minutes, 20 sessions over 4 weeks)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 28
Study: 32033152

Group type: EXPERIMENTAL
Intervention: High consumption of lactose-rich foods
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: High consumption of other FODMAP-rich foods
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: High consumption of both lactose-rich and other FODMAP-rich foods
Number of subjects: 52